Epiq Capital Group, LLC Cti Biopharma Corp Transaction History

Epiq Capital Group, LLC

  • $331 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022
SELL
$1.44 - $2.86 $174,152 - $345,885
-120,939 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$2.25 - $3.18 $272,112 - $384,586
120,939 New
120,939 $357,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Epiq Capital Group, LLC Portfolio

Follow Epiq Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epiq Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Epiq Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email